Imspex Diagnostics

Imspex is a UK-based diagnostics and device company delivering NextGenDx advanced analytical technology testing solutions to global healthcare and industry customers.

At a glance:

• Over 15 years of core GC-IMS innovation

• 400+ instruments deployed globally

• 1,000+ customer base

• £20M+ revenue generation over 5 years

• Decentralised, lab-quality testing for real-world environments

Markets served:

• Clinical diagnostics

• Industry testing,

• Veterinary diagnostics

• Defence and civil protection

• Environmental monitoring

Product/Service Imspex is redefining diagnostic and analytical testing through compact, rapid, high-sensitivity GC-IMS technology. Our core technology detects chemical and biological signatures, Volatile Organic Compounds, from any sample with detection at parts-per-billion sensitivity, in real-time.

Core capabilities:

• Bespoke development of GC-IMS testing solutions to customers

• Point-of-care clinical diagnostics

• In-line testing solutions for water, processing and manufacturing industries

• Class 2 laboratory R&D services for testing and product development

• Biological and chemical detection for defence and civil protection

• Pandemic preparedness and field-deployable testing

• Veterinary diagnostics at the point of need

Industrial applications:

• Food and beverage quality assurance

• Odour monitoring

• Gas monitoring

• Water safety testing

• Biocontamination control

• Manufacturing and production plants

Technology foundation:

• AI-driven analytics

• Integrated connectivity

• Embedded data intelligence

LifeSciDx, Imspex’s advisory platform, provides customers with tailored testing solutions and product development pathways from concept to product and regulatory approval. It transforms complex testing signals into actionable diagnostic and therapeutic pathways.